Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management

Neurotherapeutics

Volumn 13, Issue 3, 2016, Pages 493-508

  Bradshaw, Michael J ^a   Venkatesan, Arun ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aciclovir; encephalitis; HSV; meningitis; NMDA receptor; steroids

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; ELECTROLYTE;

ADULT; ADULT DISEASE; ANTIVIRAL THERAPY; BLOOD CELL COUNT; BLOOD CULTURE; CLINICAL EVALUATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; EDEMA; ELECTROENCEPHALOGRAM; HERNIA; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 1 ENCEPHALITIS; HIV TEST; HUMAN; IMMUNOCOMPROMISED PATIENT; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER FUNCTION TEST; NEUROIMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; TREATMENT DURATION; AGED; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HUMAN ALPHAHERPESVIRUS 1; PHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIVIRAL AGENTS; BRAIN; EDEMA; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; SEIZURES; TREATMENT OUTCOME;

EID: 84964300304     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-016-0433-7     Document Type: Review

References (176)

1. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013;57:1114-1128.
2. Venkatesan A. Epidemiology and outcomes of acute encephalitis. Curr Opin Neurol 2015;28:277-282.
3. Goodpasture EW. Herpetic infection, with especial reference to involvement of the nervous system. 1929. Medicine 1993;72:125-132.
4. Commission M. Epidemic encephalitis: etiology, epidemiology, treatment. Report of a survey by the Mathewson Commission. New York: Columbia university Press; 1929.
5. Smith MG, Lennette EH, Reames HR. Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol 1941;17:55-68.
6. Zarafonetis CJ, Smadel JE. Fatal herpes simplex encephalitis in man. Am J Pathol 1944;20:429-445.
7. Shieh MT, Spear PG. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J Virol 1994;68:1224-1228.
8. Mata M, Zhang M, Hu X, Fink DJ. HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol 2001;7:476-480.
9. Shukla ND, Tiwari V, Valyi-Nagy T. Nectin-1-specific entry of herpes simplex virus 1 is sufficient for infection of the cornea and viral spread to the trigeminal ganglia. Mol Vis 2012;18:2711-2716.
10. Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL. Transport and egress of herpes simplex virus in neurons. Rev Med Virol 2008;18:35-51.
11. Smith G. Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol 2012;66:153-176.
12. Mori I, Nishiyama Y, Yokochi T, Kimura Y. Olfactory transmission of neurotropic viruses. J Neurovirol 2005;11:129-137.
13. Jennische E, Eriksson CE, Lange S, Trybala E, Bergstrom T. The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection. J Neurovirol 2015;21:129-147.
14. Dinn JJ. Transolfactory spread of virus in herpes simplex encephalitis. Br Med J 1980;281:1392.
15. Ojeda VJ, Archer M, Robertson TA, Bucens MR. Necropsy study of the olfactory portal of entry in herpes simplex encephalitis. Med J Aust 1983;1:79-81.
16. Twomey JA, Barker CM, Robinson G, Howell DA. Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 1979;42:983-987.
17. Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis? Ann Neurol 1979;5:2-5.
18. Tyler KL, Tedder DG, Yamamoto LJ, et al. Recurrent brainstem encephalitis associated with herpes simplex virus type 1 DNA in cerebrospinal fluid. Neurology 1995;45:2246-2250.
19. Rose JW, Stroop WG, Matsuo F, Henkel J. Atypical herpes simplex encephalitis: clinical, virologic, and neuropathologic evaluation. Neurology 1992;42:1809-1812.
20. Hamilton RL, Achim C, Grafe MR, Fremont JC, Miners D, Wiley CA. Herpes simplex virus brainstem encephalitis in an AIDS patient. Clin Neuropathol 1995;14:45-50.
21. Steiner I, Spivack JG, O'Boyle DR, 2nd, Lavi E, Fraser NW. Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J Virol 1988;62:3493-3496.
22. Steiner I. Herpes simplex virus encephalitis: new infection or reactivation? Curr Opin Neurol 2011;24:268-274.
23. Fraser NW, Lawrence WC, Wroblewska Z, Gilden DH, Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A 1981;78:6461-6465.
24. Whitley R, Lakeman AD, Nahmias A, Roizman B. Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med 1982;307:1060-1062.
25. Medzhitov R, Janeway CA, Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300.
26. Zhang SY, Jouanguy E, Sancho-Shimizu V, et al. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007;220:225-236.
27. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004;24:439-454.
28. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809.
29. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007;317:1522-1527.
30. Zhang SY, Casanova JL. Inborn errors underlying herpes simplex encephalitis: From TLR3 to IRF3. J Exp Med 2015;212:1342-1343.
31. Andersen LL, Mork N, Reinert LS, et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med 2015;212:1371-1379.
32. Lundberg P, Ramakrishna C, Brown J, et al. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 2008;82:7078-7088.
33. Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, Lokensgard JR. Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol 2008;181:6417-6426.
34. Rock DL, Fraser NW. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 1983;302:523-525.
35. Oldstone MB. Molecular anatomy of viral persistence. J Virol 1991;65:6381-6386.
36. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 2008;6:211-221.
37. Egan KP, Wu S, Wigdahl B, Jennings SR. Immunological control of herpes simplex virus infections. J Neurovirol 2013;19:328-345.
38. Roizman B, Zhou G, Du T. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol 2011;17:512-517.
39. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl. 1):S3-S28.
40. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis 2014;209:325-333.
41. Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep 2013;13:414.
42. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-844.
43. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47:303-327.
44. Hjalmarsson A, Blomqvist P, Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 2007;45:875-880.
45. Mailles A, Stahl JP, Steering C, Investigators G. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis 2009;49:1838-1847.
46. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis 2003;36:731-742.
47. Dagsdottir HM, Sigurethardottir B, Gottfreethsson M, et al. Herpes simplex encephalitis in Iceland 1987–2011. Springerplus 2014;3:524.
48. de Ory F, Avellon A, Echevarria JE, et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 2013;85:554-562.
49. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V. Infectious encephalitis: a description of a Norwegian cohort. Scand J Infect Dis 2013;45:179-185.
50. Child N, Croxson MC, Rahnama F, Anderson NE. A retrospective review of acute encephalitis in adults in Auckland over a five-year period (2005–2009). J Clin Neurosci 2012;19:1483-1485.
51. Choi R, Kim GM, Jo IJ, et al. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis. J Med Virol 2014;86:957-962.
52. Barbadoro P, Marigliano A, Ricciardi A, D'Errico MM, Prospero E. Trend of hospital utilization for encephalitis. Epidemiol Infect 2012;140:753-764.
53. Scheld WM, Whitley RJ, Marra CM. Infections of the central nervous system. 4th ed. Philadelphia: Wolters Kluwer Health; 2014. 907 p.
54. Abel L, Plancoulaine S, Jouanguy E, et al. Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J Pediatr 2010;157:623-629, 9 e1.
55. Whitley RJ. Viral encephalitis. N Engl J Med 1990;323:242-250.
56. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. PLOS ONE 2014;9:e104169.
57. Singh TD, Fugate JE, Hocker S, Wijdicks EF, Aksamit AJ, Jr., Rabinstein AA. Predictors of outcome in HSV encephalitis. J Neurol 2016;263:277-289.
58. Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano J. Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience. Neurol Sci 2013;34:1879-1881.
59. Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL. Herpesvirus infections of the nervous system. Nat Clin Pract Neurol 2007;3:82-94.
60. Sili U, Kaya A, Mert A, Group HSVES. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 2014;60:112-118.
61. Riera-Mestre A, Gubieras L, Martinez-Yelamos S, Cabellos C, Fernandez-Viladrich P. Adult herpes simplex encephalitis: fifteen years' experience. Enferm Infecc Microbiol Clin 2009;27:143-147.
62. Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002;35:254-260.
63. Tan IL, McArthur JC, Venkatesan A, Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 2012;79:2125-2132.
64. Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 1998;29:215-222.
65. Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults—Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012;64:347-373.
66. Cesario TC, Poland JD, Wulff H, Chin TD, Wenner HA. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 1969;90:416-422.
67. Steiner I, Schmutzhard E, Sellner J, Chaudhuri A, Kennedy PG, European Federation of Neurological S, et al. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol 2012;19:1278-1291.
68. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995;171:857-863.
69. Behzad-Behbahani A, Abdolvahab A, Gholamali YP, Roshanak B, Mahmood R. Clinical signs as a guide for performing HSV-PCR in correct diagnosis of herpes simplex virus encephalitis. Neurol India 2003;51:341-344.
70. Weisberg LA, Greenberg J, Stazio A. Computed tomographic findings in acute viral encephalitis in adults with emphasis on herpes simplex encephalitis. Comput Med Imaging Graph 1988;12:385-392.
71. Leo JS, Weiner RL, Lin JP, Ransohoff J. Computed tomography in herpes simplex encephalitis. Surg Neurol 1978;10:313-317.
72. Hindmarsh T, Lindqvist M, Olding-Stenkvist E, Skoldenberg B, Forsgren M. Accuracy of computed tomography in the diagnosis of herpes simplex encephalitis. Acta Radiol Suppl 1986;369:192-196.
73. Schroth G, Gawehn J, Thron A, Vallbracht A, Voigt K. Early diagnosis of herpes simplex encephalitis by MRI. Neurology 1987;37:179-183.
74. Domingues RB, Fink MC, Tsanaclis AM, et al. Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J Neurol Sci 1998;157:148-153.
75. Misra UK, Kalita J, Phadke RV, et al. Usefulness of various MRI sequences in the diagnosis of viral encephalitis. Acta Trop 2010;116:206-211.
76. Sawlani V. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis. J Neurol Sci 2009;287:221-226.
77. McCabe K, Tyler K, Tanabe J. Diffusion-weighted MRI abnormalities as a clue to the diagnosis of herpes simplex encephalitis. Neurology 2003;61:1015-1016.
78. Kuker W, Nagele T, Schmidt F, Heckl S, Herrlinger U. Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases. Neuroradiology 2004;46:122-125.
79. Obeid M, Franklin J, Shrestha S, Johnson L, Quattromani F, Hurst D. Diffusion-weighted imaging findings on MRI as the sole radiographic findings in a child with proven herpes simplex encephalitis. Pediatr Radiol 2007;37:1159-1162.
80. Okanishi T, Yamamoto H, Hosokawa T, et al. Diffusion-weighted MRI for early diagnosis of neonatal herpes simplex encephalitis. Brain Develop 2015;37:423-431.
81. Dhawan A, Kecskes Z, Jyoti R, Kent AL. Early diffusion-weighted magnetic resonance imaging findings in neonatal herpes encephalitis. J Paediatr Child Health 2006;42:824-826.
82. Duckworth JL, Hawley JS, Riedy G, Landau ME. Magnetic resonance restricted diffusion resolution correlates with clinical improvement and response to treatment in herpes simplex encephalitis. Neurocrit Care 2005;3:251-253.
83. Renard D, Nerrant E, Lechiche C. DWI and FLAIR imaging in herpes simplex encephalitis: a comparative and topographical analysis. J Neurol 2015;262:2101-2105.
84. Chow FC, Glaser CA, Sheriff H, et al. Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics. Clin Infect Dis 2015;60:1377-1383.
85. Lai CW, Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol 1988;5:87-103.
86. Verma R, Raut TP, Giri P, Praharaj HN. New onset refractory status epilepticus (NORSE) as the heralding manifestation of herpes simplex encephalitis. BMJ Case Rep 2013;2013.
87. Sellner J, Trinka E. Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management. J Neurol 2012;259:2019-2030.
88. Brodtkorb E, Lindqvist M, Jonsson M, Gustafsson A. Diagnosis of herpes simplex encephalitis. A comparison between electroencephalography and computed tomography findings. Acta Neurol Scand 1982;66:462-471.
89. Upton A, Gumpert J. Electroencephalography in diagnosis of herpes-simplex encephalitis. Lancet 1970;1:650-652.
90. Sutter R, Kaplan PW, Cervenka MC, et al. Electroencephalography for diagnosis and prognosis of acute encephalitis. Clin Neurophysiol 2015;126:1524-1531.
91. Ch'ien LT, Boehm RM, Robinson H, Liu C, Frenkel LD. Characteristic early electroencephalographic changes in herpes simplex encephalitis. Arch Neurol 1977;34:361-364.
92. Illis LS, Taylor FM. The electroencephalogram in herpes-simplex encephalitis. Lancet 1972;1:718-721.
93. Whitley RJ, Cobbs CG, Alford CA, Jr., et al. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA 1989;262:234-239.
94. Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 2015 Dec 17 [Epub ahead of print].
95. Whitley RJ, Soong SJ, Linneman C, Jr., Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. Clinical Assessment. JAMA 1982;247:317-320.
96. Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 1994;36:823-829.
97. Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 1996;53:125-133.
98. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002;34:1154-1157.
99. Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007;119:e399-e407.
100. De Tiege X, Heron B, Lebon P, Ponsot G, Rozenberg F. Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin Infect Dis 2003;36:1335-1339.
101. Venkatesan A, Geocadin RG. Diagnosis and management of acute encephalitis: A practical approach. Neurol Clin Pract 2014;4:206-215.
102. Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 1996;275:470-473.
103. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986;314:144-149.
104. Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet 1984;2:707-711.
105. Whitley RJ, Gnann JW, Jr. Acyclovir: a decade later. N Engl J Med 1992;327:782-789.
106. Hirsch MS, Swartz MN. Drug therapy: antiviral agents (second of two parts). N Engl J Med 1980;302:949-953.
107. Heintz BH, Matzke GR, Dager WE. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009;29:562-577.
108. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983;12(Suppl. B):29-37.
109. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure. Clinical course and histology. Am J Med 1988;84:1067-1071.
110. Pacheco LR, Tavares HM, Moyses Neto M, et al. [Acute renal failure related to intravenous acyclovir]. Rev Assoc Med Bras 2005;51:275-278.
111. Adair JC, Gold M, Bond RE. Acyclovir neurotoxicity: clinical experience and review of the literature. South Med J 1994;87:1227-1231.
112. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010;304:859-866.
113. Rozenberg F, Deback C, Agut H. Herpes simplex encephalitis: from virus to therapy. Infect Disord Drug Targets 2011;11:235-250.
114. Chatis PA, Crumpacker CS. Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother 1992;36:1589-1595.
115. Levin MJ, Bacon TH, Leary JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 2004;39(Suppl. 5):S248-S257.
116. Erlich KS, Mills J, Chatis P, et al. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989;320:293-296.
117. Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial. Am J Med 1992;92:30S-35S.
118. Losada I, Canizares A, Hellin T, Marti-Belda P, Guerrero A. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?]. Enferm Infecc Microbiol Clin 2002;20:25-27.
119. Superti F, Ammendolia MG, Marchetti M. New advances in anti-HSV chemotherapy. Curr Med Chem 2008;15:900-911.
120. Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 1994;48:199-226.
121. Trifillis AL, Cui X, Drusano GL. Use of human renal proximal tubule cell cultures for studying foscarnet-induced nephrotoxicity in vitro. Antimicrob Agents Chemother 1993;37:2496-2499.
122. Markham A, Faulds D. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 1994;48:455-484.
123. VanLandingham KE, Marsteller HB, Ross GW, Hayden FG. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA 1988;259:1051-1053.
124. Dennett C, Klapper PE, Cleator GM. Polymerase chain reaction in the investigation of "relapse" following herpes simplex encephalitis. J Med Virol 1996;48:129-132.
125. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, van Loon AM. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry 1996;61:339-345.
126. Solomon T, Hart IJ, Beeching NJ. Viral encephalitis: a clinician's guide. Pract Neurol 2007;7:288-305.
127. Gnann JW, Jr., Skoldenberg B, Hart J, et al. Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy. Clin Infect Dis 2015;61:683-691.
128. Meyding-Lamade UK, Oberlinner C, Rau PR, et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 2003;9:118-125.
129. Habel AH, Brown JK. Dexamethasone in herpes-simplex encephalitis. Lancet 1972;1:695.
130. Upton AR, Foster JB, Barwick DD. Dexamethasone treatment in herpes-simplex encephalitis. Lancet 1971;1:861.
131. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005;76:1544-1549.
132. Martinez-Torres F, Menon S, Pritsch M, et al. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol 2008;8:40.
133. Conrady CD, Drevets DA, Carr DJ. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 2010;220:1-9.
134. van Crevel H, Hijdra A, de Gans J. Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002;249:129-137.
135. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001;345:1727-1733.
136. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-1859.
137. Kalanuria AA, Geocadin RG, Puttgen HA. Brain code and coma recovery: aggressive management of cerebral herniation. Semin Neurol 2013;33:133-141.
138. Kamel H, Navi BB, Nakagawa K, Hemphill JC, 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011;39:554-559.
139. Safain MG, Roguski M, Kryzanski JT, Weller SJ. A review of the combined medical and surgical management in patients with herpes simplex encephalitis. Clin Neurol Neurosurg 2015;128:10-16.
140. Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology 2013;81:793-800.
141. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008;49(Suppl. 6):13-18.
142. Kalita J, Nair PP, Misra UK. Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs. J Neurovirol 2008;14:412-417.
143. Pandey S, Rathore C, Michael BD. Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis. Cochrane Database Syst Rev 2014;10:CD010247.
144. Hocker SE. Status epilepticus. Continuum 2015;21(5 Neurocritical Care):1362-1383.
145. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
146. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-637.
147. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006;67:340-342.
148. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-532.
149. Trinka E, Hofler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs 2014;28:623-639.
150. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-798.
151. Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014;82:656-664.
152. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014;75:317-323.
153. Armangue T, Moris G, Cantarin-Extremera V, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015;85:1736-1743.
154. Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes 2004;11(Suppl. 2):57A-64A.
155. Kimberlin DW. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 2007;14:11-16.
156. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006;71:141-148.
157. Stahl JP, Mailles A, De Broucker T, Steering C, Investigators Group. Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol Infect 2012;140:372-381.
158. Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology 2014;82:443-451.
159. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis 2002;35:175-182.
160. Kim YS, Jung KH, Lee ST, et al. Prognostic value of initial standard EEG and MRI in patients with herpes simplex encephalitis. J Clin Neurol 2016;12:224-229.
161. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997;63:321-326.
162. Poissy J, Wolff M, Dewilde A, et al. Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis. Clin Microbiol Infect 2009;15:560-564.
163. De Tiege X, Rozenberg F, Des Portes V, et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003;61:241-243.
164. Barthez-Carpentier MA, Rozenberg F, Dussaix E, et al. Relapse of herpes simplex encephalitis. J Child Neurol 1995;10:363-368.
165. Ito Y, Kimura H, Yabuta Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 2000;30:185-187.
166. Schleede L, Bueter W, Baumgartner-Sigl S, et al. Pediatric herpes simplex virus encephalitis: a retrospective multicenter experience. J Child Neurol 2013;28:321-331.
167. Barthez MA, Billard C, Santini JJ, Ruchoux MM, Grangeponte MC. Relapse of herpes simplex encephalitis. Neuropediatrics 1987;18:3-7.
168. Skoldenberg B, Aurelius E, Hjalmarsson A, et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 2006;253:163-170.
169. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013;162:850-856 e2.
170. Leypoldt F, Titulaer MJ, Aguilar E, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology 2013;81:1637-1639.
171. Bektas O, Tanyel T, Kocabas BA, Fitoz S, Ince E, Deda G. Anti-N-methyl-D-aspartate receptor encephalitis that developed after herpes encephalitis: a case report and literature review. Neuropediatrics 2014;45:396-401.
172. Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902-911.
173. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014;29:90-96.
174. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord 2014;29:117-122.
175. Bradshaw MJ, Pawate S, Lennon VA, Bloch KC, Brown KM. Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity. Neurology 2015;85:2176-2177.
176. Johnston C, et al. Status of vaccine research and development of vaccines for herpes simplex virus prepared for WHO PD-VAC. Vaccine 2016 Mar 11 [Epub ahead of print].